Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Developing Predictive Models to Distinguish Alcohol Use, Cannabis Use and Co-use: An Exploration of Electroencephalography (EEG) Metrics and Traditional Intoxication Measures
Who can join
Ages 21 to 50 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 21-50 years old * Heavy drinkers (consuming more than 4 drinks/day or more than 14 drinks/week for men, or more than 3 drinks/day or more than 7 drinks/week for women) * Regular users of legal-market flower cannabis (at least 2x/week in past 3 months) * report simultaneously using alcohol and legal-market flower cannabis at least once per month in the past 3 months * English speakers. Exclusion Criteria: * Daily tobacco users * Diagnosed with or seeking treatment for alcohol use disorder (AUD) or other substance use disorder (SUD) * Females cannot be pregnant, breastfeeding or trying to become pregnant * Meet criteria for psychotic, bipolar or major depressive disorder with suicidal ideation, or history of these disorders, 5) Current use of psychotropic (except anti-depressants) * Report illicit drug use in past 60-days or fail drug screen on the day of the study appointment * Major medical condition contraindicating alcohol and/or cannabis consumption.
About the study
This is a randomized, parallel-group study designed to explore the differences between cannabis intoxication, alcohol intoxication and co-intoxication involving both alcohol and cannabis, utilizing electroencephalography (EEG) as well as more traditional intoxication measures such as breath alcohol concentration and balance metrics. If eligible for the study, participants will be randomized to complete one study session in our mobile laboratory, during which they will use either alcohol, cannabis (which will be self-administered, ad libitum) or both alcohol and cannabis.
What is being tested
- Alcohol (other)
- Cannabis (other)
Sponsor: Colorado State University · Participants: 99 · Started: Jan 5, 2024
Contact the study team
- Hollis C Karoly, PhD · Phone: 970-491-3677
- Patricia Davies, PhD · Phone: (970) 491-7294
Official record on ClinicalTrials.gov — NCT06259916
Locations in the U.S.
| Colorado | Colorado State University, Fort Collins |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.